CPX-351 (Liposomal Cytarabine and Daunorubicin)
Treatment used for 1 condition
Total Trials
43
Total Participants
1K
Avg Effectiveness
78%
Avg Safety Score
25%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.